1. Dual-Axis Receptor Physiology
The secretion of growth hormone (GH) by anterior pituitary somatotrope cells is tightly regulated by two distinct pathways:
GHRH Receptor Pathway (CJC-1295 / Mod-GRF 1-29)
Stimulates adenylate cyclase → increases intracellular cAMP → activates protein kinase A (PKA) → initiates transcription and synthesis of new growth hormone molecules.
GHS-R1a Pathway (Ipamorelin)
Activates phospholipase C (PLC) → triggers IP3 and diacylglycerol (DAG) → releases intracellular $\text{Ca}^{2+}$ stores → triggers immediate exocytotic release of stored GH vesicles.
2. Why Ipamorelin Has High Selectivity
Earlier generation GH secretagogues (such as GHRP-6 and GHRP-2) non-selectively stimulated pituitary receptors, resulting in unwanted spikes in:
- Cortisol: Inducing catabolic adrenal stress responses.
- Prolactin: Inducing gynaecomastia and suppressing gonadotropins.
- Extreme Appetite (Ghrelin): Due to non-selective hunger center binding.
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) engineered to bind exclusively to the GHS-R1a receptor with near-zero affinity for ACTH or prolactin secretagogue channels, making it the most selective GHRP tested in clinical research.
3. Research Synergistic Ratio
When co-administered in equal microgram ratios ($100 \, \mu\text{g}$ CJC-1295 / Mod-GRF 1-29 and $100 - 200 \, \mu\text{g}$ Ipamorelin), research demonstrates a multiplicative, rather than merely additive, GH pulse amplitude.
📚 Key Studies
- Raun K, et al. "Ipamorelin, the first selective growth hormone secretagogue." Eur J Endocrinol. 1998;139(5):552-61. PMID: 9849822.
- Teichman SL, et al. "Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295." J Clin Endocrinol Metab. 2006;91(3):799-805. PMID: 16352683.
- Bowers CY. "Growth hormone-releasing peptides: structure, mechanism, and clinical potential." Cell Mol Life Sci. 1998;54(12):1316-29.